Research on Financial Fraud and Audit Failure of Listed Companies——Taking Kangmei Pharmaceutical as an Example
A
BSTRACT
In April 2019, Kangmei Pharmaceutical released its 2018 annual audit report and "Announcement on Correction of Early Accounting Errors". The error announcement showed that Kangmei Pharmaceutical conducted retroactive adjustments to 22 items in the 2017 consolidated statement, of which monetary funds The project was reduced by nearly 30 billion yuan. The 2018 annual report
上市公司财务舞弊与审计失败研究-11565字.docx